Researchers at the Francis Crick Institute and the Gulbenkian Institute for Molecular Medicine (GIMM) have discovered that ...

Parasite Clearance in Patients with Plasmodium vivax or P. falciparum Malaria Treated with Multiple 400-mg Doses or a Single 800-mg Dose of KAF156. Most patients had at least one adverse event.

To protect themselves from that fate, the parasites deploy grappling hooks called PfEMP1 (plasmodium falciparum erythrocyte membrane protein 1) onto the outside of the red blood cells, latching ...

In 2022, nearly 619,000 global deaths due to malaria were caused by Plasmodium falciparum, the most virulent, prevalent, and deadly human malaria parasite. For decades, the parasite's resistance ...

Plasmodium falciparum, responsible for severe forms, is found mainly in Sub-Saharan Africa, where a child dies of malaria every two minutes. In 2021, 247 million cases and 619,000 deaths were ...

Partial resistance of Plasmodium falciparum to the artemisinin component of artemisinin-based combination therapies, the most important malaria drugs, emerged in Southeast Asia and now threatens ...

Scientists have identified the regional character to Plasmodium falciparum across Africa. Malaria, infecting 219 million individuals in 2017, remains a threat to public health and regional stability.